Epigral Performance
- Today's Low
- ₹1,042
- Today's High
- ₹1,089
- 52 Week Low
- ₹807
- 52 Week High
- ₹2,114
- Open Price₹1,042
- Previous Close₹1,052
- Volume57,257
- 50 DMA₹1,097.70
- 100 DMA₹1,129.80
- 200 DMA₹1,240.50
Epigral Chart
Investment Returns
- Over 1 Month -3.94%
- Over 3 Month -9.81%
- Over 6 Month -5.64%
- Over 1 Year -39.77%
Smart Investing Starts Here Start SIP with Epigral for Steady Growth!
Epigral Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.1
- PEG Ratio
- -2
- Market Cap Cr
- 4,673
- P/B Ratio
- 2.1
- Average True Range
- 44.2
- EPS
- 76.9
- Dividend Yield
- 0.5
- MACD Signal
- -25.3
- RSI
- 46.33
- MFI
- 65.37
Latest Stock News Updates
Revised Credit Rating.
- BSE India
- 5 days 21 hours ago
Epigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2026
- BSE India
- 1 week 4 days ago
Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
- BSE India
- 1 week 5 days ago
Epigral Financials
Epigral Technicals
EMA & SMA
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹1,061.50
- 50 Day
- ₹1,097.70
- 100 Day
- ₹1,129.80
- 200 Day
- ₹1,240.50
Resistance and Support
- R3 1,102.80
- R2 1,086.40
- R1 1,069.10
- S1 1,035.40
- S2 1,019.00
- S3 1,001.70
Epigral Corporate Actions - Bonus, Splits, Dividends
About Epigral
Epigral is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. View More- NSE Symbol
- EPIGRAL
- BSE Symbol
- 543332
- ISIN
- INE071N01016
Similar Stocks to Epigral
Popular Stocks
Epigral FAQs
Epigral share price is ₹1,083 As on 20 July, 2026 | 15:52
The Market Cap of Epigral is ₹4673.1 Cr As on 20 July, 2026 | 15:52
The P/E ratio of Epigral is 14.1 As on 20 July, 2026 | 15:52
The PB ratio of Epigral is 2.1 As on 20 July, 2026 | 15:52
The 52 week High & Low of Epigral is ₹2114/₹807 respectively As on 20 July, 2026 | 15:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.